Summary
The American Heart Association diet guidelines are driving renewed debate across the United States by promoting plant-based eating, reduced sugar intake, and long-term cardiovascular health, while differing from current...
Eli Lilly and Company, a renowned pharmaceutical company, has unveiled the complete results from its Phase 3 trial of Mounjaro (tirzepatide) for the treatment of obesity or overweight. The findings were published in Nature Medicine and were also presented at the ObesityWeek 2023 conference.
Key Takeaways:
Eli Lilly's Mounjaro is...
In a bid to further its commitment to the healthcare sector, tech giant Microsoft has announced a series of enhancements to its Cloud for Healthcare platform. These updates, centered around artificial intelligence (AI) and data management, aim to provide healthcare professionals with more comprehensive, data-driven insights and improved clinical...
In a recent development, Novo Nordisk, a global pharmaceutical giant, has raised concerns over the proliferation of counterfeit versions of its renowned weight-loss drug, Wegovy, and its diabetes medication, Ozempic. These fake drugs are being increasingly offered for sale on various online platforms.
Rising Concerns Over Online Sales
Novo Nordisk's alarm...
In a move set to revolutionize the healthcare sector, Google Cloud has announced the launch of new artificial intelligence-powered search functionalities. These advanced capabilities aim to assist healthcare workers in swiftly and accurately retrieving clinical information from various medical records.
Key Highlights:
Enhanced Search: The new AI-driven search features are...
